NAD+ IV

Nicotinamide Adenine Dinucleotide (NAD+) is a coenzyme found in all living cells, vital for numerous biological processes. It plays a crucial role in metabolism, energy production, DNA repair, and gene expression (PubChem). As people age, NAD+ levels naturally decline. NAD+ intravenous (IV) infusions are a method of directly administering this coenzyme into the bloodstream, aiming to bypass issues with oral absorption and potentially deliver higher concentrations to cells and tissues. This approach is explored for its potential in promoting cellular health, supporting metabolic functions, and influencing aspects of the aging process. The rationale behind NAD+ IV infusions often centers on replenishing cellular NAD+ stores in the hopes of enhancing cellular function and resilience. While NAD+ is naturally produced by the body, various factors, including aging and chronic stress, can contribute to its depletion. Research into NAD+ and its precursors (such as nicotinamide riboside and nicotinamide mononucleotide) is ongoing across various health domains (Examine.com). The direct IV administration of NAD+ is a subject of active scientific and clinical investigation to understand its efficacy, safety, and optimal application for different health objectives.